Found 4 matching trials
the Efficacy and Safety of Anlotinib Combined With Almonertinib in the First-line Treatment of Patients With Brain Metastases From EGFR Mutation-positive Non-small Cell Lung Cancer PHASE2 Subject population:Patients with brain metastases from EGFR mutation-positi...
Show More Location
Sun Yat-Sen University Cancer Center
Learn More & Join Trial
Almonertinib Combined With Anlotinib as First-line Treatment for Advanced Non-small Cell Lung Cance PHASE3 To evaluate the efficacy and safety of almonertinib plus anlotinib as first...
Show More Learn More & Join Trial
A Clinical Study of the Combination of Anlotinib and Aumolertinib in the First-line Treatment of Advanced NSCLC With EGFR 21L858R Mutation NA This study is a prospective, multicenter, single arm clinical study. Thirty...
Show More Location
First Affiliated Hospital of Kunming University
Learn More & Join Trial
Safety and Efficacy of Aumolertinib Combined With Anlotinib as 1st Line Treatment in Advanced Lung Cancer EGFR Mutation With TP53 Co-Mutation PHASE2 The goal of this open, single-arm, exploratory phase II clinical study is t...
Show More Location
Multiple Locations
Learn More & Join Trial